Therapeutic Efficacies of GW471552 and GW471558, Two New Azasordarin Derivatives, against Pneumocystosis in Two Immunosuppressed-Rat Models
Elena Jiménez(GlaxoSmithKline (Spain)), Domingo Gargallo‐Viola(GlaxoSmithKline (United Kingdom)), El Moukhtar Aliouat(Inserm), Antonio Martı́nez(Hospital Universitario de Móstoles), Jesús Caballero Caballero(Cañada College), Eduardo Dei‐Cas(Inserm)
Cited by 9
Related Papers
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
|Proceedings of the National Academy of Sciences|2013|519
Improved Murine Model of Malaria Using<i>Plasmodium falciparum</i>Competent Strains and Non-Myelodepleted NOD-<i>scid IL2R</i>γ<sup><i>null</i></sup>Mice Engrafted with Human Erythrocytes
|Antimicrobial Agents and Chemotherapy|2009|189
A Murine Model of falciparum-Malaria by In Vivo Selection of Competent Strains in Non-Myelodepleted Mice Engrafted with Human Erythrocytes
|PLoS ONE|2008|164
Synthesis and Structure–Activity Relationships of 4-Pyridones as Potential Antimalarials
|Journal of Medicinal Chemistry|2008|139